Masazumi Kojima

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

Koichiro Ogata, Jeanne Mendell‐Harary, Masaya Tachibana et al. · The Journal of Clinical Pharmacology · 2010 · 446 citations

Pharmacological Study, Medicine, Clinical Safety +10

Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols

Yoshio Kuno, Masazumi Kojima, Shuichi Ando et al. · Journal of Controlled Release · 2005 · 115 citations

Engineering, Medicine, Downstream Processing +8

Development of controlled release matrix pellets by annealing with micronized water-insoluble or enteric polymers

Masazumi Kojima, Hiroaki Nakagami · Journal of Controlled Release · 2002 · 47 citations

Materials Science, Engineering, Polymer Science +4

Magnetic Resonance Imaging (MRI) Study of Swelling and Water Mobility in Micronized Low-Substituted Hydroxypropylcellulose Matri Tablets.

Masazumi Kojima, Shuichi Ando, KATSUO KATAOKA et al. · Chemical and Pharmaceutical Bulletin · 1998 · 37 citations · Full text

Biopolymer Gel, Engineering, Lh41 Tablet +6

Effect of preparation method on properties of orally disintegrating tablets made by phase transition

Yoshio Kuno, Masazumi Kojima, Shuichi Ando et al. · International Journal of Pharmaceutics · 2007 · 30 citations

Preparation Method, Excipients, Medicine +4